Showing results (391-400 of 1,011) with videos related to

Sort By:
Pageof 102
La Revue De Medecine Interne|January 1, 1997
[Severe hemorrhagic complications during treatment with low molecular weight heparin. Apropos of 2 cases]G Grateau, L Chauvenet, S Oudard, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1975
[Chronic pulmonary artery thrombosis. Therapeutic modality. Apropos of 6 cases]J Acar, C Cabrol, M Samama, et al.
Thrombosis Research|April 23, 2003
Comparative study of the pharmacokinetic profiles of two LMWHs--bemiparin (3500 IU, anti-Xa) and tinzaparin (4500 IU, anti-Xa)--administered subcutaneously to healthy male volunteersF Depasse, M J González de Suso, I Lagoutte, et al.
Chest|July 24, 2008
Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Jack Hirsh, Kenneth A Bauer, Maria B Donati, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1990
[Peri- and postoperative use of low molecular weight heparin in peripheral vascular surgery]C M Samama, S Mouren, M P Bridel, et al.
Thrombosis and Haemostasis|December 1, 1996
The antithrombotic potential of dalteparin in man assessed indirectly by Wessler's techniqueJ Millet, J Theveniaux, G Tachon, et al.
Seminars in Thrombosis and Hemostasis|April 1, 1987
Specific determination and identification of cross-linked fibrin degradation products in patients under thrombolytic therapy for myocardial infarctionJ Soria, C Soria, M Mirshahi, et al.
Annales Francaises D'Anesthesie Et De Reanimation|September 3, 2013
[Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors. Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013]G Pernod, P Albaladejo, A Godier, et al.
Archives of Cardiovascular Diseases|July 2, 2013
Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013Gilles Pernod, Pierre Albaladejo, Anne Godier, et al.
Thrombosis and Haemostasis|July 3, 2009
Differential inhibition of thrombin generation by vitamin K antagonists alone and associated with low-molecular-weight heparinGrigoris T Gerotziafas, Charlotte Dupont, Alex C Spyropoulos, et al.
Pageof 102